Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 16/20 | 0.40 |
| ▸ | CMA1 | P23946 | 2/20 | 0.37 |
| ▸ | XIAP | P98170 | 1/20 | 0.36 |
| ▸ | MLX | Q9UH92 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8660922 | 0.91 | ELANE (0.39) | ELANE | |
| SCHEMBL2289363 | 0.85 | ELANE (0.42) | ELANECMA1XIAPMLX | |
| SCHEMBL8665933 | 0.85 | EP300 (0.37) | ELANE | |
| SCHEMBL10895690 | 0.83 | ELANE (0.42) | ELANECMA1 | |
| SCHEMBL8662040 | 0.82 | ELANE (0.40) | ELANECMA1XIAPMLX | |
| SCHEMBL7410732 | 0.82 | ELANE (0.43) | ELANECMA1XIAPMLX | |
| SCHEMBL847832 | 0.81 | CMA1 (0.49) | CMA1XIAP | |
| SCHEMBL228960 | 0.81 | ELANE (0.38) | ELANECMA1XIAPMLX | |
| SCHEMBL5487413 | 0.81 | ELANE (0.38) | ELANECMA1XIAPMLX | |
| SCHEMBL3276266 | 0.79 | ELANE (0.42) | ELANECMA1XIAPMLX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3071688-A1 | MICROSPHERE-BASED DELIVERY AND EX VIVO MANIPULATION OF DENDRITIC CELLS FOR AUTOIMMUNE THERAPIES | University of Pittsburgh - Of the Commonwealth System of Higher Education (US) | 2016-09-28 | — | — | EP | disclosed |
| WO-2015074057-A1 | MICROSPHERE-BASED DELIVERY AND EX VIVO MANIPULATION OF DENDRITIC CELLS FOR AUTOIMMUNE THERAPIES | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2015-05-21 | — | — | WO | disclosed |
| EP-2673381-A2 | BIOPROBES AND METHODS OF USE THEREOF | The Governing Council Of The University Of Toronto (CA) | 2013-12-18 | — | — | EP | disclosed |
| WO-2012109157-A2 | BIOPROBES AND METHODS OF USE THEREOF | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2012-08-16 | — | — | WO | disclosed |
| EP-1805220-A1 | METHOD FOR TREATING TUMORS USING ANTI-OSTEOPONTIN ANTIBODIES | GENENTECH, INC. (US) | 2007-07-11 | — | — | EP | disclosed |
| WO-2006043954-A1 | METHOD FOR TREATING TUMORS USING ANTI-OSTEOPONTIN ANTIBODIES | GENENTECH, INC. (US) | 2006-04-27 | — | — | WO | disclosed |
| US-6743591-B1 | FOR HIGHER ACCURACY USING AN AUTOMATED COUNTER | ARKRAY, INC. (JP) | 2004-06-01 | — | — | US | disclosed |
| WO-2003063803-A1 | BIOACTIVE BOTANICAL COSMETIC INGREDIENTS AND PROCESSES FOR THEIR PRODUCTION | INTEGRATED BOTANICAL TECHNOLOGIES, LLC (US) | 2003-08-07 | — | — | WO | disclosed |
| WO-2000035905-A1 | INHIBITORS OF β-LACTAMASES AND USES THEREFOR | NORTHWESTERN UNIVERSITY (US) | 2000-06-22 | — | — | WO | disclosed |
| EP-0114777-B1 | EXPRESSION VEHICLES AND THEIR USE IN THE PREPARATION OF A PROTEIN HAVING HUMAN ALPHA-ANTITRYPSIN ACTIVITY | TRANSGENE S.A. (FR) | 1990-08-01 | — | — | EP | disclosed |
| US-4551279-A | Protease inhibitors | G. D. SEARLE & CO. (US) | 1985-11-05 | — | — | US | disclosed |
| EP-0156100-A2 | 3-Substituted hydroxypentanedioic acids, -hemiesters or -anhydrides | G.D. Searle & Co. (US) | 1985-10-02 | — | — | EP | disclosed |
| EP-0148752-A2 | Protease inhibitors | G.D. Searle & Co. (US) | 1985-07-17 | — | — | EP | disclosed |
| US-4501895-A | ELASTIN DEGRADATION INHIBITION | G.D. SEARLE & CO. (US) | 1985-02-26 | — | — | US | disclosed |
| US-4499295-A | Protease inhibitors | G. D. SEARLE & CO. (US) | 1985-02-12 | — | — | US | disclosed |
| EP-0126372-A1 | Halogenated protease inhibitors | G.D. Searle & Co. (US) | 1984-11-28 | — | — | EP | disclosed |
| EP-0124905-A1 | Protease inhibitors | G.D. Searle & Co. (US) | 1984-11-14 | — | — | EP | disclosed |
| US-4469885-A | Halogenated protease inhibitors | G. D. SEARLE & CO. (US) | 1984-09-04 | — | — | US | disclosed |
| WO-1984002918-A1 | NEW EXPRESSION VECTORS AND APPLICATION THEREOF TO THE PREPARATION OF A PROTEIN HAVING THE ACTIVITY OF HUMAN ANTITRYPSIN-alpha1 | TRANSGENE SA (FR) | 1984-08-02 | — | — | WO | disclosed |
| EP-0114777-A2 | Expression vehicles and their use in the preparation of a protein having human alpha-antitrypsin activity | TRANSGENE S.A. (FR) | 1984-08-01 | — | — | EP | disclosed |